AIRLINK 196.20 Increased By ▲ 4.36 (2.27%)
BOP 10.16 Increased By ▲ 0.29 (2.94%)
CNERGY 7.92 Increased By ▲ 0.25 (3.26%)
FCCL 38.30 Increased By ▲ 0.44 (1.16%)
FFL 15.90 Increased By ▲ 0.14 (0.89%)
FLYNG 25.44 Increased By ▲ 0.13 (0.51%)
HUBC 130.65 Increased By ▲ 0.48 (0.37%)
HUMNL 13.79 Increased By ▲ 0.20 (1.47%)
KEL 4.66 Decreased By ▼ -0.01 (-0.21%)
KOSM 6.38 Increased By ▲ 0.17 (2.74%)
MLCF 44.95 Increased By ▲ 0.66 (1.49%)
OGDC 209.79 Increased By ▲ 2.92 (1.41%)
PACE 6.68 Increased By ▲ 0.12 (1.83%)
PAEL 41.05 Increased By ▲ 0.50 (1.23%)
PIAHCLA 17.75 Increased By ▲ 0.16 (0.91%)
PIBTL 8.13 Increased By ▲ 0.06 (0.74%)
POWER 9.38 Increased By ▲ 0.14 (1.52%)
PPL 180.99 Increased By ▲ 2.43 (1.36%)
PRL 40.00 Increased By ▲ 0.92 (2.35%)
PTC 24.41 Increased By ▲ 0.27 (1.12%)
SEARL 111.75 Increased By ▲ 3.90 (3.62%)
SILK 0.99 Increased By ▲ 0.02 (2.06%)
SSGC 38.17 Decreased By ▼ -0.94 (-2.4%)
SYM 19.22 Increased By ▲ 0.10 (0.52%)
TELE 8.75 Increased By ▲ 0.15 (1.74%)
TPLP 12.10 Decreased By ▼ -0.27 (-2.18%)
TRG 66.00 Decreased By ▼ -0.01 (-0.02%)
WAVESAPP 12.29 Decreased By ▼ -0.49 (-3.83%)
WTL 1.69 Decreased By ▼ -0.01 (-0.59%)
YOUW 3.99 Increased By ▲ 0.04 (1.01%)
BR100 12,090 Increased By 159.6 (1.34%)
BR30 35,982 Increased By 322.6 (0.9%)
KSE100 114,866 Increased By 1659.2 (1.47%)
KSE30 36,099 Increased By 534 (1.5%)

Karachi: The Drug Regulatory Authority of Pakistan (DRAP) in Wednesday agreed to increase price of Paracetamol tablets from Rs. 1.90 per tablet to Rs 2.65 per tablet, sources privy to the development told Business Recorder.

In this regard, the sources explained, a summary would be forwarded to federal cabinet for approval. Former chairman Pakistan Pharmaceutical Manufact-urers Association (PPMA) Dr Kaiser Waheed said Paracetamol availability was disturbed for a short period due to non-availability of basic ingredients to manufacture its active raw material

He informed that some of the factories, producing active ingredient of in china, were closed down due to certain reasons. Noteworthy to mention here that, Pakistan is facing extreme shortage of various brands of Paracetamol at the moment amid Covid-19 third wave and growing dengue, typhoid and malaria cases.

Copyright Business Recorder, 2022

Comments

Comments are closed.